Cite
Herviou P, Thivat E, Richard D, et al. Therapeutic drug monitoring and tyrosine kinase inhibitors. Oncol Lett. 2016;12(2):1223-1232doi: 10.3892/ol.2016.4780.
Herviou, P., Thivat, E., Richard, D., Roche, L., Dohou, J., Pouget, M., Eschalier, A., Durando, X., & Authier, N. (2016). Therapeutic drug monitoring and tyrosine kinase inhibitors. Oncology letters, 12(2), 1223-1232. https://doi.org/10.3892/ol.2016.4780
Herviou, Pauline, et al. "Therapeutic drug monitoring and tyrosine kinase inhibitors." Oncology letters vol. 12,2 (2016): 1223-1232. doi: https://doi.org/10.3892/ol.2016.4780
Herviou P, Thivat E, Richard D, Roche L, Dohou J, Pouget M, Eschalier A, Durando X, Authier N. Therapeutic drug monitoring and tyrosine kinase inhibitors. Oncol Lett. 2016 Aug;12(2):1223-1232. doi: 10.3892/ol.2016.4780. Epub 2016 Jun 24. PMID: 27446421; PMCID: PMC4950523.
Copy
Download .nbib